Todd A. Alonzo

Also affiliated with California Library Association

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.3Author DataRank

Indexed papers

4in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Childhood cancer data initiative: expanded access to tumor molecular profiling for children, adolescents, and young adults

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf214

Top 42%

0.448DataRank

Top 42%7 citations

Subhashini Jagu, Malcolm A. Smith, John Shern, Douglas S. Hawkins, Elaine R. Mardis +26 more

Papers

Driven by 43 papers — median percentile 43. Top paper: “Ulixertinib in patients with tumors with MAPK pathway alterations: Results from NCI-COG Pediatric MATCH trial Arm J (APEC1621J).”.

Ulixertinib in patients with tumors with MAPK pathway alterations: Results from NCI-COG Pediatric MATCH trial Arm J (APEC1621J).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3009

N/A

0.518DataRank · unranked

16 citations

Amit J. Sabnis, Paul M. Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +15 more

Childhood cancer data initiative: expanded access to tumor molecular profiling for children, adolescents, and young adults

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf214

Top 42%

0.448DataRank

Top 42%7 citations

Subhashini Jagu, Malcolm A. Smith, John Shern, Douglas S. Hawkins, Elaine R. Mardis +26 more

Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G

The Oncologist(2024)10.1093/oncolo/oyae119

N/A

0.363DataRank · unranked

7 citations

AeRang Kim, P. Mickey Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +17 more

Cancer Informatics for Cancer Centers: Scientific Drivers for Informatics, Data Science, and Care in Pediatric, Adolescent, and Young Adult Cancer

JCO Clinical Cancer Informatics(2021)10.1200/cci.21.00040

N/A

0.341DataRank · unranked

4 citations

Anne C. Kirchhoff, Jaime M. Guidry Auvil, Norman E. Sharpless, Kara L. Davis, Karlyne M. Reilly +26 more

Sociodemographic and Socioeconomic Factors Correlate with Late-Stage Pediatric Hodgkin Lymphoma and Rhabdomyosarcoma: A Report from the Children’s Oncology Group Registries

Cancer Epidemiology Biomarkers & Prevention(2024)10.1158/1055-9965.epi-24-0510

Top 55%

0.295DataRank

Top 55%4 citations

Heydon K. Kaddas, Todd A. Alonzo, Logan G. Spector, Negar Fallahazad, Emily Owens +4 more

Population-Based Data Linkage Describing Patterns of Cancer Clinical Trial Enrollment Among Children and Adolescents

JCO Oncology Practice(2024)10.1200/op.23.00325

Top 58%

0.271DataRank

Top 58%4 citations

Eric B. Durbin, Brad H. Pollock, Allison Grimes, Lingyun Ji, Todd A. Alonzo +9 more

Update for NCI-COG Pediatric MATCH: Active trial cohorts for children, adolescents and young adults with refractory cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps10071

Top 59%

0.257DataRank

Top 59%3 citations

Katherine A. Janeway, Theodore W. Laetsch, Meredith S. Irwin, Elizabeth Alva, Christine A. Pratilas +14 more

Molecular risk markers define risk of relapse in myeloid leukemia of Down syndrome beyond measurable residual disease

Blood Advances(2025)10.1182/bloodadvances.2025017837

N/A

0.104DataRank · unranked

1 citations

Anupam Verma, Shelton A. Viola, Todd A. Alonzo, Yicheng Wang, Lisa Eidenschink Brodersen +15 more

Cytarabine Pharmacogenomics and Outcomes Among Children and Young Adults With Acute Myeloid Leukemia

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.16296

N/A

0.104DataRank · unranked

1 citations

Vivek M. Shastri, Deedra Nicolet, Krzysztof Mrózek, Christopher J. Walker, William Blum +19 more

Factors impacting enrollment on NCI-COG Pediatric MATCH trial treatment protocols.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10007

N/A

0DataRank · unranked

3 citations

Katherine A. Janeway, David R. Patton, Jennifer Lee, Brent Coffey, P. Mickey Williams +16 more

Selumetinib in patients with tumors with MAPK pathway alterations: Results from Arm E of the NCI-COG pediatric MATCH trial.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10008

N/A

0DataRank · unranked

2 citations

Olive S. Eckstein, P. Mickey Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +15 more

Integrated Genomic Analysis Identifies UBTF Tandem Duplications as a Recurrent Lesion in Pediatric Acute Myeloid Leukemia

Blood Cancer Discovery(2022)10.1158/2643-3230.bcd-21-0160

N/A

0DataRank · unranked

100 citations

Jing Ma, Benjamin J. Huang, Kohei Hagiwara, Tamara Westover, Sherif Abdelhamed +43 more

Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemia

Nature Communications(2022)10.1038/s41467-022-33244-6

N/A

0DataRank · unranked

49 citations

Jenny L. Smith, Jason E. Farrar, Yi‐Cheng Wang, Masayuki Umeda, Rhonda E. Ries +21 more

IL-10 and TNFα are associated with decreased survival in low-risk pediatric acute myeloid leukemia; a children’s oncology group report

Pediatric Hematology and Oncology(2022)10.1080/08880018.2022.2089790

N/A

0DataRank · unranked

11 citations

Terzah M. Horton, Chana L. Glasser, Robert B. Gerbing, Richard Aplenc, Todd A. Alonzo +2 more

Tazemetostat in patients with tumors with alterations in EZH2 or the SWI/SNF complex: Results from NCI-COG Pediatric MATCH trial Arm C (APEC1621C).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.10009

N/A

0DataRank · unranked

21 citations

Joanna S. Yi, P. Mickey Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +15 more

Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad085

N/A

0DataRank · unranked

95 citations

Joanna S. Yi, P. Mickey Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +17 more

Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia

Haematologica(2023)10.3324/haematol.2022.281653

N/A

0DataRank · unranked

76 citations

Jenny L. Smith, Lauren Harmon, Rhonda E. Ries, Yi-Cheng J. Wang, Todd A. Alonzo +32 more

Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication

Nature Communications(2023)10.1038/s41467-023-37438-4

N/A

0DataRank · unranked

39 citations

Jonathon Klein, Richa Bajpai, Li Dong, Quang Tran, Pandurang Kolekar +28 more

Children's Oncology Group's 2023 blueprint for research: Myeloid neoplasms

Pediatric Blood & Cancer(2023)10.1002/pbc.30584

N/A

0DataRank · unranked

26 citations

Todd A. Alonzo, Sarah K. Tasian, Matthew A. Kutny, Johann Hitzler, Jessica A. Pollard +4 more

Long Noncoding RNA Expression Independently Predicts Outcome in Pediatric Acute Myeloid Leukemia

Journal of Clinical Oncology(2023)10.1200/jco.22.01114

N/A

0DataRank · unranked

30 citations

Jenny L. Smith, Megan Othus, Benjamin J. Huang, Yicheng Wang, Rhonda E. Ries +14 more

Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology Group

Pediatric Blood & Cancer(2023)10.1002/pbc.30251

N/A

0DataRank · unranked

26 citations

Jenny L. Smith, Amy Heerema‐McKenney, John Choi, Rhonda E. Ries, Betsy Hirsch +10 more

CREBBP Alterations are Associated with A Poor Prognosis in de novo AML

Blood(2023)10.1182/blood.2022017545

N/A

0DataRank · unranked

14 citations

Kohei Hagiwara, Robert B. Gerbing, Jenny L. Smith, Pandurang Kolekar, Rhonda E. Ries +5 more

Valosin‐containing protein (VCP/p97) is prognostically unfavorable in pediatric AML, and negatively correlates with unfolded protein response proteins IRE1 and GRP78: A report from the Children's Oncology Group

PROTEOMICS - CLINICAL APPLICATIONS(2023)10.1002/prca.202200109

N/A

0DataRank · unranked

4 citations

Yihua Qiu, Brandon D. Brown, Robert B. Gerbing, Amanda R. Leonti, Rhonda E. Ries +9 more

SAMHD1 single nucleotide polymorphisms impact outcome in children with newly diagnosed acute myeloid leukemia

Blood Advances(2023)10.1182/bloodadvances.2022009088

N/A

0DataRank · unranked

6 citations

Xueyuan Cao, Huiyun Wu, Abdelrahman H. Elsayed, Jeffery M. Klco, Raul C. Ribeiro +10 more

Association of the social disorganization index with time to first septic shock event in children with acute myeloid leukemia

Cancer(2023)10.1002/cncr.35109

N/A

0DataRank · unranked

1 citations

Yimei Li, Lusha Cao, Yuan‐Shung Huang, Vicky Tam, Heather Griffis +11 more

Palbociclib in solid tumor patients with genomic alterations in the cyclin D-CDK4/6-INK4a-Rb pathway: Results from NCI-COG pediatric MATCH trial Arm I (APEC1621I).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10006

N/A

0DataRank · unranked

4 citations

Rajen Mody, Joel M. Reid, Jin Piao, Lauren Saguilig, Todd A. Alonzo +14 more

Reply to Z.R. McCaw et al

Journal of Clinical Oncology(2023)10.1200/jco.23.00986

N/A

0DataRank · unranked

0 citations

Megan Othus, Yicheng Wang, Todd A. Alonzo, Soheil Meshinchi, Jason E. Farrar

A new genomic framework to categorize pediatric acute myeloid leukemia

Nature Genetics(2024)10.1038/s41588-023-01640-3

N/A

0DataRank · unranked

112 citations

Jing Ma, Tamara Westover, Yonghui Ni, Guangchun Song, Jamie L. Maciaszek +18 more

Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia

Blood Advances(2024)10.1182/bloodadvances.2023011771

N/A

0DataRank · unranked

29 citations

Christine J. Harrison, Kim Klein, Yilin Jiang, Jonas Abrahamsson, Todd A. Alonzo +30 more

CD74 is expressed in a subset of pediatric acute myeloid leukemia patients and is a promising target for therapy: a report from the Children’s Oncology Group

Haematologica(2024)10.3324/haematol.2023.283757

N/A

0DataRank · unranked

10 citations

Chad A. Hudson, Todd A. Alonzo, Robert B. Gerbing, Laura Pardo, Amanda R. Leonti +18 more

Integrated drug resistance and leukemic stemness gene-expression scores predict outcomes in large cohort of over 3500 AML patients from 10 trials

npj Precision Oncology(2024)10.1038/s41698-024-00643-5

N/A

0DataRank · unranked

7 citations

Xueyuan Cao, Richard J Marrero, Nam Nguyen, Huiyun Wu, Yonhui Ni +16 more

Bayesian semiparametric model for sequential treatment decisions with informative timing

Biostatistics(2024)10.1093/biostatistics/kxad035

N/A

0DataRank · unranked

7 citations

Kelly Getz, Todd A. Alonzo, Richard Aplenc, Jason Roy, Arman Oganisian

Long-read epigenomic diagnosis and prognosis of Acute Myeloid Leukemia

Research Square(2024)10.21203/rs.3.rs-5450972/v1

N/A

0DataRank · unranked

1 citations

Marieke Landwehr, Ann-Kathrin Schade, Vivek M. Shastri, Matin Ghavami, Fernando Sckaff +21 more

Enrollment in Children’s Oncology Group’s clinical trials: population-based linkage with the National Childhood Cancer Registry

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf134

N/A

0DataRank · unranked

6 citations

David A. Siegel, Nicola Schussler, Todd A. Alonzo, Suzanne Adams, David Angelaszek +20 more

Erdafitinb in patients with FGFR-altered tumors: Results from the NCI-COG Pediatric MATCH trial arm B (APEC1621B).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10007

N/A

0DataRank · unranked

20 citations

Alexander J. Chou, P. Mickey Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +15 more

Heat shock factor 1 (HSF1-pSer326) predicts response to bortezomib-containing chemotherapy in pediatric AML: a COG report

Blood(2020)10.1182/blood.2020005208

N/A

0DataRank · unranked

15 citations

Anneke D. van Dijk, Yihua Qiu, Peter P. Ruvolo, Robert B. Gerbing, Amanda R. Leonti +11 more

Genomic Variants of Cytarabine Sensitivity Associated with Treatment-Related Mortality in Pediatric AML: A Report from the Children's Oncology Group

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3117

N/A

0DataRank · unranked

4 citations

Adam Lane, Robert B. Gerbing, Todd A. Alonzo, Alyss Wilkey, Gretchen A. Radloff +5 more

CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children’s Oncology Group

Blood(2021)10.1182/blood.2020009652

N/A

0DataRank · unranked

122 citations

Adam J. Lamble, Yi‐Cheng Wang, Robert B. Gerbing, Rhonda E. Ries, Michael R. Loken +13 more

Mesothelin is a novel cell surface disease marker and potential therapeutic target in acute myeloid leukemia

Blood Advances(2021)10.1182/bloodadvances.2021004424

N/A

0DataRank · unranked

41 citations

Sonali P. Barwe, Anilkumar Gopalakrishnapillai, Rhonda E. Ries, Todd A. Alonzo, Robert B. Gerbing +16 more

Comparison of the Transcriptomic Signatures in Pediatric and Adult CML

Cancers(2021)10.3390/cancers13246263

N/A

0DataRank · unranked

22 citations

Stephanie M. Smith, Alex Gia Lee, Hee‐Don Chae, Elizabeth Spiteri, Jason Erdmann +24 more

CBFB-MYH11 fusion transcripts distinguish acute myeloid leukemias with distinct molecular landscapes and outcomes

Blood Advances(2021)10.1182/bloodadvances.2021004965

N/A

0DataRank · unranked

11 citations

Jenny L. Smith, Yi‐Cheng Wang, Kassra Taghizadeh, Amanda R. Leonti, Rhonda E. Ries +19 more

Bortezomib is significantly beneficial for de novo pediatric AML patients with low phosphorylation of the NF‐κB subunit RelA

PROTEOMICS - CLINICAL APPLICATIONS(2021)10.1002/prca.202100072

N/A

0DataRank · unranked

9 citations

Fieke W. Hoff, Yihua Qiu, Robert B. Gerbing, Alan S. Gamis, Richard Aplenc +8 more

Aberrantly low STAT3 and STAT5 responses are associated with poor outcome and an inflammatory gene expression signature in pediatric acute myeloid leukemia

Clinical & Translational Oncology(2021)10.1007/s12094-021-02621-w

N/A

0DataRank · unranked

8 citations

Tsz‐Kwong Man, Robert B. Gerbing, Rhonda E. Ries, Alexandra M. Stevens, Y.-C. Wang +7 more

Todd A. Alonzo

Indexed papers

Top data-sharing exemplar

Papers